Mesalamine Tablet, Delayed Release
Product Images NDC 63304-175

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 63304-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl Mesalamine Label1

Label for Mesalamine Delayed-Release Tablets USP, 1.2 g per tablet, oral dosage form in a pack of 120 tablets. The label includes storage instructions, pharmacist dispensing information, and distribution/manufacturing details for Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Limited, India. The product is prescription-only and features a barcode and child-resistant packaging note.*

FDA Label Image

Spl Mesalamine Structure

Chemical structure of mesalamine, showing a benzene ring substituted with an amino group, a carboxylic acid group, and a hydroxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.